• LOGIN
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publication
  • Projects
  • Funding
  • Research Data
  • Organizations
  • Researchers
  • LOGIN
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Home artificial nutrition in Switzerland: an epidemiological survey from 2005 to 2009.
 

Home artificial nutrition in Switzerland: an epidemiological survey from 2005 to 2009.

Options
  • Details
BORIS DOI
10.7892/boris.53998
Date of Publication
2013
Publication Type
Article
Division/Institute

Universitätsklinik fü...

Author
Shaw, Susy Ann
Rühlin, Maya
Wagener, Nicole
Stanga, Zeno
Universitätsklinik für Diabetologie, Endokrinologie, Ernährungsmedizin & Metabolismus (UDEM)
Meier, Rémy
Ballmer, Peter E
Subject(s)

600 - Technology::610...

Series
Annals of nutrition & metabolism
ISSN or ISBN (if monograph)
1421-9697
Publisher
Karger
Language
English
Publisher DOI
10.1159/000346485
PubMed ID
23485820
Description
BACKGROUND AND AIMS

Home artificial nutrition (HAN), including oral nutritional supplements (ONS) and enteral (HEN) and parenteral (HPN) nutrition, is an established, important treatment for malnourished patients. The aim of this study was to analyze the epidemiological data of patients on HAN in Switzerland.

METHODS

This retrospective study recorded all new cases of HAN in Switzerland from January 2005 to December 2009.

RESULTS

A total of 12,917 cases were recorded: 6,731 (52%) males and 6,186 (48%) females, with a mean age of 65.0 ± 17.6 years. The number of patients on ONS was 7,827 (57.4%), on HEN 3,966 (39.4%) and on HPN 433 (3.2%). The most common underlying disease category was neoplasms (6,519, 50.7%). The number of patients on ONS increased from 57.0% (n = 1,252) to 60.8% (n = 2,039), and on HPN from 2.1% (n = 45) to 4.0% (n = 134) between 2005 and 2009.

CONCLUSIONS

This first analysis of the large-scale Swiss registry of HAN shows that approximately half of the patients received ONS, whereas HPN was rarely delivered. The frequency of ONS and HPN increased from the year 2005 to 2009. In accordance with previous European studies, malignant tumors were by far the most frequent indication for HAN.
Handle
https://boris-portal.unibe.ch/handle/20.500.12422/124421
Show full item
File(s)
FileFile TypeFormatSizeLicensePublisher/Copright statementContent
10.1159-000346485.pdftextAdobe PDF163.39 KBpublishedOpen
BORIS Portal
Bern Open Repository and Information System
Build: b407eb [23.05. 15:47]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo